Argenx
ARGX
#440
Rank
C$81.65 B
Marketcap
C$1,307
Share price
0.34%
Change (1 day)
75.10%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): C$22.07

According to Argenx 's latest financial reports the company's current EPS (TTM) is C$22.45. In 2025 the company made an earnings per share (EPS) of C$29.94 an increase over its 2024 EPS that were of C$19.77.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$22.07-26.28%
2025C$29.9451.44%
2024C$19.77-369.77%
2023C-$7.33-60.46%
2022C-$18.5363.33%
2021C-$11.35-40.37%
2020C-$19.03183.47%
2019C-$6.71123.09%
2018C-$3.0154.93%
2017C-$1.9414.07%
2016C-$1.7013.05%
2015C-$1.51-36.34%
2014C-$2.37209.04%
2013C-$0.77-33.99%
2012C-$1.16185.59%
2011C-$0.41